Publications

Peer-reviewed publications

Search for von Deimling, A. publications on

(since 2000)

Ino, Y., Zlatescu, M., Sasaki, H., Macdonald, D., Stemmer-Rachamimov, A., Jhung, S., Ramsay, D., von Deimling, A., Louis, D., and Cairncross, G. (2000). Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. J Neurosurg 92, 983-990.

Kivi, A., Lehmann, T., Kovacs, R., Eilers, A., Jauch, R., Meencke, H., von Deimling, A., Heinemann, U., and Gabriel, S. (2000). Effects of barium on stimulus-induced rises of [K+]o in human epileptic non-sclerotic and sclerotic hippocampal area CA1. Eur J Neurosci 12, 2039-2048.

Kraus, J., Wenghoefer, M., Schmidt, M., von Deimling, A., Berweiler, U., Roggendorf, W., Diete, S., Dietzmann, K., Müller, B., Heuser, K., et al. (2000). Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation. J Neurol 247, 455-460.

Louis, D.N., Scheithauer, B.W., Budka, H., von Deimling, A., and Kepes, J. (2000). Meningiomas. In Pathology & Genetics, Tumours of the Nervous System, P. Kleihues, and W. Cavanee, eds. (Lyon, IARCpress), pp. 176-184.

Nelson, J.S., von Deimling, A., Petersen, I., and Jancer, R. (2000). Metastatic tumours of the CNS. In Pathology & Genetics, Tumours of the Nervous System, P. Kleihues, and W. Cavanee, eds. (Lyon, IARCpress), pp. 250-253.

Ohgaki, H., Peraud, A., Nakazato, Y., Watanabe, K., and von Deimling, A. (2000). Giant cell glioblastoma. In Pathology & Genetics, Tumours of the Nervous System, P. Kleihues, and W. Cavanee, eds. (Lyon, IARCpress), pp. 40-41.

Parry, L., Maynard, J., Patel, A., Hodges, A., von Deimling, A., Sampson, J., and Cheadle, J. (2000). Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours. Hum Genet 107, 350-356.

Petersen, I., Hidalgo, A., Petersen, S., Schlüns, K., Schewe, C., Pacyna-Gengelbach, M., Goeze, A., Krebber, B., Knösel, T., Kaufmann, O., et al. (2000). Chromosomal imbalances in brain metastases of solid tumors. Brain Pathol 10, 395-401.

Smith, J., Tachibana, I., Lee, H., Quian, J., Pohl, U., Mohrenweiser, H., Borell, T., Hosek, S., Soderberg, C., von Deimling, A., et al. (2000). Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers. Genes Chromosomes Cancer 29, 16-25.

von Deimling, A., Fimmers, R., Schmidt, M.C., Bender, B., Fassbender, F., Nagel, J., Jahnke, R., Kaskel, P., Duerr, E.-M., Koopmann, J., et al. (2000). Comprehensive allelotype and genetic analysis of 466 human nervous system tumors. J Neuropathol Exp Neurol 59, 544-558.

von Deimling, A., Foster, R., and Krone, W. (2000). Neurofibromatosis type 1. In Pathology & Genetics, Tumours of the Nervous System, P. Kleihues, and W. Cavanee, eds. (Lyon, IARCpress), pp. 216-218.

Weggen, S., Bayer, T.A., von Deimling, A., Reifenberger, G., von Schweinitz, D., Wiestler, O.D., and Pietsch, T. (2000). Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol 10, 85-92.

Zhou, X.-P., Smith, W., Gimm, O., Mueller, E., Gao, X., Sarraf, P., Prior, T., Plass, C., von Deimling, A., Black, P., et al. (2000). Over-representationof PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumor risk in the general population. J Med Genet 37, 410-414.

Becker, A., Löbach, M., Klein, H., Normann, S., Nöthen, M., von Deimling, A., Mizuguchi, M., Elger, C., Schramm, J., Wiestler, O., et al. (2001). Mutational analysis of TSC1 and TSC2 genes in gangliogliomas. Neuropathol Appl Neurobiol 27, 105-114.

Gath, R., Goessling, A., Keller, K.-M., Koletzko, S., Coerdt, W., Müntefering, H., Wirth, S., Hofstra, R., Mulligan, L., Eng, C., et al. (2001). Analysis of the RET, GDNF, EDN3 and EDNRB genes in patients with Intestinal neuronal Dysplasia (IND) and Hirschsprung disease (HSCR). Gut 48, 671-675.

Hayashi, Y., Iwato, M., Hasegawa, M., Tachibana, O., von Deimling, A., and Yamashita, J. (2001). Malignant transformation of a gangliocytoma / ganglioglioma into a glioblastoma multiforme: a molecular genetic analysis. J Neurosurg 95, 138-142.

Jeuken, J., Sprenger, S., Boerman, R., von Deimling, A., Teepen, H., van Overbeeke, J., and Wesseling, P. (2001). Subtyping of oligo-astrocytic tumors by comparative genomic hybridization. J Pathol 194, 81-87.

Joachim, T., Ram, Z., Rappaport, Z., Simon, M., Schramm, J., Wiestler, O., and von Deimling, A. (2001). Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas. Int J Cancer 94, 218-221.

Kluwe, L., von Deimling, A., Hagel, C., Tatagiba, M., Stavrou, D., Ostertag, H., and Mautner, V. (2001). Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas. J Neuropathol Exp Neurol 60, 917-920.

Kraus, J., De Millas, W., Sorensen, N., Herbold, C., Schichor, C., Tonn, J., Wiestler, O., von Deimling, A., and Pietsch, T. (2001). Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1. Acta Neuropathologica 102, 69-74.

Kraus, J., Wenghoefer, M., Glesmann, N., Schröder, R., Berweiler, U., Roggendorf, W., Diete, S., Dietzmann, K., Heuser, K., von Deimling, A., et al. (2001). TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme. J Neurooncol 52, 263-272.

Mueller, W., Lass, U., Herms, J., Kuchelmeister, K., and von Deimling, A. (2001). Clonal analysis in glioblastoma with epithelial differentiation. Brain Pathol 11, 39-43.

Przkora, R., Meyer-Puttlitz, B., Schmitt, O., Berthold, F., Nöthen, M., Kraus, J., Tonn, J., von Deimling, A., Wiestler, O., and Pietsch, T. (2001). Analysis of the TSC2 gene in human mendulloblastoma. Acta Neuropathol (Berl) 102, 380-384.

Schmitz, U., Mueller, W., Weber, M., Sevenet, N., Delattre, O., and von Deimling, A. (2001). INI1 mutations in meningiomas at a potential hotspot in exon 9. Br J Cancer 84, 199-201.

van Landeghem, F., Stover, J., Bechmann, I., W., B., Unterberg, A., Buhrer, C., and von Deimling, A. (2001). Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia 35, 167-179.

Vanhorne, J.B., Gimm, O., Myers, S., Kaushik, A., von Deimling, A., Eng, C., and Mulligan, L. (2001). Cloning and characterization of the human GFRA2 locus and investigation of the gene in Hirschsprung Disease. Human Genet 108, 409-415.

Weber, M., Stockhammer, F., Schmitz, U., and von Deimling, A. (2001). Mutational analysis of INI1 in sporadic human brain tumors. Acta Neuropathologica 101, 479-482.

Kaulich, K., Blaschke, B., Numann, A., von Deimling, A., Wiestler, O., Weber, R., and Reifenberger, G. (2002). Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas. J Neuropathol Exp Neurol 61, 1092-1099.

Kiening, K., van Landeghem, F., Schreiber, S., Thomale, U., von Deimling, A., Unterberg, A., and Stover, J. (2002). Decreased hemispheric Aquaporin-4 is linked to evolving brain edema following controlled cortical impact injury in rats. Neuroscience Letters 324, 105-108.

Krude, H., Schutz, B., Biebermann, H., von Moers, A., Schnabel, D., Neitzel, H., Toennies, H., Weise, D., Lafferty, A., Schwarz, S., et al. (2002). Choreoathetosis, hypothyroidism and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 109, 475-480.

Mollenhauer, J., Müller, H., Kollender, G., Lyer, S., Diedrichs, S., Helmke, B., Holmskov, U., Ligtenberg, T., Herbertz, S., Krebs, I., et al. (2002). The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer. Genes Chrom Cancer 35, 242-255.

Mueller, W., Hartmann, C., Hoffmann, A., Lanksch, W., Kiwit, J., Tonn, J., Veelken, J., Schramm, J., Weller, M., Wiestler, O., et al. (2002). Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. American Journal Pathology 161, 313-319.

Mueller, W., Mollenhauer, J., Stockhammer, F., Poustka, A., and von Deimling, A. (2002). Rare mutations of the DMBT1 gene in human astrocytic gliomas. Oncogene 21, 5956-5959.

Schmidt, M., Antweiler, S., Urban, N., Mueller, W., Meyer-Puttlitz, B., Wiestler, O., Louis, D., Fimmers, R., and von Deimling, A. (2002). Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 61, 321-328.

Hartmann, C., Mueller, W., Laß, U., Stockhammer, F., von Eckardstein, K., Veelken, J., Jeuken, J., Wick, W., and von Deimling, A. (2003). No preferential loss of paternal 19q alleles in oligodendroglial tumors. Ann Neurol 54, 256-258.

Mautner, V., Friedrich, R., von Deimling, A., Hagel, C., Korf, B., Knofel, R., Wenzel, R., and Funsterer, C. (2003). Malignant peripheral nerve sheath tumors in Neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma. Neuroradiology 45, 618-625.

Mawrin, C., Kirches, E., Schneider-Stock, R., Scherlach, C., Vorwerk, C., von Deimling, A., van Landeghem, F., Meyermann, R., Bornemann, A., Muller, A., et al. (2003). Analysis of TP53 and PTEN in gliomatosis cerebri. Acta Neuropathol Berl 105, 529-536.

Nutt, C.L., Mani, D., Betensky, R., Tamayo, P., Cairncross, J., Ladd, C., Pohl, U., Hartmann, C., Mc Laughlin, M., Batchelor, T., et al. (2003). Gene Expression-based Classification of Malignant Gliomas Correlates Better with Survival than Histological Classification. Cancer Res 63, 1602-1607.

Rhiem, K., Klein, A., Munch, M., Kreutzfeld, R., Ramser, J., Wardelmann, E., Schackert, G., von Deimling, A., Wiestler, O., and Schmutzler, R. (2003). Chromosomal region 15q21.1 is a frequent target of allelic imbalance in advanced breast carcinomas. Int J Cancer 106, 74-77.

van Landeghem, F., Schreiber, S., Unterberg, A., von Deimling, A., and Stover, J. (2003). Differential concentration-dependent effects of prolonged norepinephrine infusion on intraparenchymal hemorrhage and cortical contusion in brain-injured rats. Journal of Neurotrauma 20, 1327-1337.

Zang, C., Wachter, M., Liu, H., Posch, M., Fenner, M., Stadelmann, C., von Deimling, A., Possinger, K., Black, K., Koeffler, H.P., et al. (2003). Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas. J Neuro-Oncol 65, 107-118.

Harder, A., Rosche, M., Reuss, D., Holtkamp, N., Uhlmann, K., Friedrich, R., Mautner, V., and von Deimling, A. (2004). Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours. European Journal of Cancer 40, 2820-2828.

Hartmann, C., Nuemann, A., Mueller, W., Holtkamp, N., Simon, M., and von Deimling, A. (2004). Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma. Int J Cancer 108, 839-844.

Hartmann, C., Xu, X., Bartels, G., Holtkamp, N., Atallah, I., Tallen, G., and von Deimling, A. (2004). PDGFR-alpha in 1p/19q LOH oligodendrogliomas. Int J Cancer.

Holtkamp, N., Mautner, V., Friedrich, R., Harder, A., Hartmann, C., Theallier-Janko, A., Hoffmann, K., and von Deimling, A. (2004). Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors. Acta Neuropathol Berl 107, 159-168.

Holtkamp, N., Reuß, D., Atallah, I., Kuban, R., Hartmann, C., Mautner, V.-F., Frahm, S., Friedrich, R., Algermissen, B., Pham, V.-A., et al. (2004). Subclassification of nerve sheath tumors by gene expression profiling. Brain Pathol 14, 258-264.

Mueller, W., Eum, J.-H., Lass, U., Paulus, W., Sarkar, C., Bruck, W., and von Deimling, A. (2004). No evidence of hSNF5/INI1 mutations in choroid plexus papilloma. Neuropathol Appl Neurobiol 30, 304-307.

Posch, M., Mueller, W., Zang, C., Lass, U., von Deimling, A., and Elstner, E. (2004). Somatic mutations in peroxisome proliferator-activated receptor gamma are rare events in human cancer cells. Medical Science Monitor 10, 250-254.

Tallen, G., Kaiser, I., Krabbe, S., Lass, U., Hartmann, C., Henze, G., Riabowol, K., and von Deimling, A. (2004). No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma. Int J Cancer 109, 476-479.

Upadhyaya, M., Han, S., Consoli, C., Majounie, E., Horan, M.P., Thomas, N., Potts, C., Griffiths, S., Ruggiere, M., von Deimling, A., et al. (2004). Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors. Hum Mutat 23, 134-146.

Diaz de Stahl, T., Hartmann, C., de Bustos, C., Piotrowski, A., Benetkiewicz, M., Matripragada, K., Tykwinski, T., von Deimling, A., and Dumanski, J. (2005). Chromosome 22 tiling path array-CGH analysis identifies germline- and tumor-specific aberrations in patients with glioblastoma multiforme. Genes Chrom Cancer 44, 161-169.

Hartmann, C., Bartels, G., Gehlhaar, C., Holtkamp, N., and von Deimling, A. (2005). PIK3CA mutations in glioblastoma multiforme. Acta Neuropathol (Berl) 109, 639-642.

Holtkamp, N., Afanasieva, A., Elstner, A., van Landeghem, F., Könneker, M., Kuhn, S., Kettenmann, H., and von Deimling, A. (2005). Brain slice invasion model reveals genes differentially regulated in glioma invasion. Biochem Biophys Res Commun 336, 1227-1233.

Kotchetkov, R., Hernáiz Driever, P., Cinatl, J., Michaelis, M., Karaskova, J., Blaheta, R., Squire, J., von Deimling, A., Moog, J., and Cinatl Jr, J. (2005). Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression. Int J Oncol 27, 1029-1037.

Mawrin, C., E., K., Schneider-Stock, R., Boltze, K., C., V., von Deimling, A., Stoltenburg-Didinger, G., Bornemann, A., Romeike, B., Sellhaus, B., et al. (2005). Alterations of cell cycle regulators in gliomatosis cerebri. J Neurooncol 72, 115-122.

Mawrin, C., Schneider, T., Firsching, R., Wiedemann, F., Dietzmann, K., Bornemann, A., Romeike, B., Sellhaus, B., and von Deimling, A. (2005). Assessment of tumor cell invasion factors in gliomatosis cerebri. J Neuro-Oncol 73, 109-115.

Michaelis, S., Okuducu, A., Sarioglu, N., von Deimling, A., and Dudenhausen, J. (2005). The transcription factor ETS-1 is expressed in human amniochorionic membranes and is upregulated in term and preterm premature ruptured membranes. J Perinat Med 33, 314-319.

Montesinos-Rongen, M., Schmitz, R., Courts, C., Stemzel, W., Bechtel, D., Niedobitek, G., Blümcke, I., Reifenberger, G., von Deimling, A., Jungnickel, B., et al. (2005). Absence of Immunoglobulin Class Switch in Primary Lymphomas of the Central Nervous System. Am J Pathol 166, 1773 - 1779.

Mueller, W., Laß, U., Wellmann, S., Kunitz, F., and von Deimling, A. (2005). Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas. Acta Neuropathol (Berl) 109, 314-320.

Rahnenführer, J., Beerenwinkel, N., Schulz, W., Hartmann, C., von Deimling, A., Wullich, B., and Lengauer, T. (2005). Estimating cancer survival and clinical outcome based on genetic tumor progression scores. Bioinformatics 21, 2438-2446.

Wemmert, S., Ketter, R., Rahnenführer, J., Beerenwinkel, N., Strowitzki, M., Feiden, W., Hartmann, C., Stockhammer, F., Lengauer, T., Zang, K., et al. (2005). Patients with high grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment. Neoplasia 7, 883-893.

Biebermann, H., Castaneda, T., van Landeghem, F., von Deimling, A., Escher, F., Brabant, G., Hebebrand, J., Hinney, A., Tschoep, M., Gruters, A., et al. (2006). A role for beta-melanocytic stimulating hormone in human body weight regulation. Cell Metabolism 3, 141-146.

Brenner, W., Friedrich, R., Gawad, K., Hagel, C., von Deimling, A., de Wit, M., Buchert, R., Clausen, M., and Mautner, V.-F. (2006). Prognostic relevance of FDG Pet in patients with neurofibromatosis type 1 and malignant peripheral nerve sheath tumors. Eur J Nucl Med Mol Imaging 33, 428-432.

Harder, A., Mautner, V.-F., Friedrich, R., Harder, T., Plagemann, A., and von Deimling, A. (2006). Transcription factor AP-2 is expressed in human schwann cell derived tumors. Histopathology 49, 441-443.

Hartmann, C., Devermann, L., Gelhaar, C., Holtkamp, N., and von Deimling, A. (2006). PIK3CA mutations in oligodendroglial tumors. Neuropathol Appl Neurobiol 32, 209-212.

Hartmann, C., Sieberns, J., Gelhaar, C., Simon, M., Paulus, W., and von Deimling, A. (2006). NF2 mutations in secretory and other rare variants of meningiomas. Brain Pathol 16, 15-19.

Holtkamp, N., Okuducu, A., Mucha, J., Afanasieva, A., Atallah Gonzalez, I., Hartmann, C., Estevez-Schwarz, L., Mawrin, C., Friedrich, R., Mautner, V.-F., et al. (2006). Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity. Carcinogenesis 27, 664-671.

Jordan, A., Scholz, R., Maier-Hauff, K., van Landeghem, F., Waldoefner, N., Teichgraeber, U., Pinkernelle, J., Bruhn, H., Neumann, F., Thiesen, B., et al. (2006). The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol 78, 7-14.

Mueller, W., Lass, U., Veelken, J., F., R., and von Deimling, A. (2006). 45- year old male with symptomatic mass in the frontal lobe. Brain Pathol 16, 89-90.

Okuducu, A., Zils, U., Michaelis, S., Mawrin, C., and von Deimling, A. (2006). Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9. Cancer 107, 1365-1372.

Okuducu, A., Zils, U., Michaelis, S., S., M., and von Deimling, A. (2006). Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas. Histopathology 48, 836-845.

Tews, B., Felsberg, J., Hartmann, C., Kunitz, A., Hahn, M., Toedt, G., Neben, K., Hummerich, L., von Deimling, A., Reifenberger, G., et al. (2006). Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling. Int J Cancer 119, 792-800.

van Landeghem, F., Weiss, T., Oehmichen, M., and von Deimling, A. (2006). Decreased expression of glutamate transporters in astrocytes after human traumatic brain injury. Journal of Neurotrauma 23, 1518-1528.

Blumcke, I., Pauli, E., Clusmann, H., Schramm, J., Becker, A., Elger, C., Merschhemke, M., Meencke, H., Lehmann, T., von Deimling, A., et al. (2007). A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol (Berl) 113, 235-244.

Elstner, A., Holtkamp, N., and von Deimling, A. (2007). Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cells. Clin Exp Metastasis 24, 57-66.

Hagel, C., Zils, U., Peiper, M., Kluwe, L., Zurakowski, D., von Deimling, A., and Mautner, V.-F. (2007). Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors. J Neuro-Oncol 82, 187-192.

Holtkamp, N., Ziegenhagen, N., Malzer, E., Hartmann, C., Giese, A., and von Deimling, A. (2007). Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme. Neuro-Oncology 9, 291-297.

Kunitz, A., Wolter, M., van den Boom, J., Felsberg, J., Tews, B., Hahn, M., Benner, A., Sabel, M., Lichter, P., Reifenberger, G., et al. (2007). DNA hypermethylation and Aberrant Expression of the EMP3 Gene at 19q13.3 in Human Gliomas. Brain Pathol.

Maier-Hauff, K., Rothe, R., Scholz, R., Gneveckow, U., Wust, P., Thiesen, B., Feussner, A., von Deimling, A., Waldoefner, N., Felix, R., et al. (2007). Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neuro-Oncol 81, 53-60.

Michaelis, M., Cinatl, J., Anand, P., Rothweiler, F., Kotchetkov, R., von Deimling, A., Doerr, H., Shogen, K., and Cinatl Jr, J. (2007). Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells. Cancer Letters 18, 107-116.

Mueller, W., Nutt, C.L., Ehrich, M., Riemenschneider, M.J., von Deimling, A., van den Boom, D., and Louis, D.N. (2007). Downregulation of RUNX3 and TES by hypermethylation in glioblastoma. Oncogene 256, 583-593.

Mueller, W., Schneider, H., K., H., Zschenderlein, R., and von Deimling, A. (2007). Granulomatous tissue response in germinoma, a diagnostic pitfall in endoscopic biopsy. Neuropathlogy 27, 127-132.

Rickert, C.H., Schwering, E.M., Siebers, J., Hartmann, C., von Deimling, A., and Paulus, W. (2007). Chromosomal imbalances and NF2 mutational analysis in a series of 10 spinal nerve sheath myxomas. Histopathology 50, 252-257.

Stockhammer, F., Thomale, U., Plotkin, M., Hartmann, C., and von Deimling, A. (2007). Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas. J Neurosurg 106, 633-637.

Tews, B., Roerig, P., Hartmann, C., Hahn, M., Felsberg, J., Blaschke, B., Sabel, M., Kunitz, A., Toedt, G., Neben, K., et al. (2007). Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Oncogene 26, 5010-5016.

van Landeghem, F.K., Weiss, T., Oehmichen, M., and von Deimling, A. (2007). Cellular localization of pituitary adenylate cyclase-activating peptide (PACAP) following traumatic brain injury in humans. Acta Neuropathol (Berl) 113, 683-693.

Holtkamp, N., Atallah, I., Okuducu, A.F., Mucha, J., Hartmann, C., Mautner, V.F., Friedrich, R.E., Mawrin, C., and von Deimling, A. (2007). MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors. Neoplasia 9, 671-677.

Krex, D., Klink, B., Hartmann, C., Von Deimling, A., Pietsch, T., Simon, M., Sabel, M., Steinbach, J., Heese, O., Reifenberger, G., et al. (2007). Long-term survival with glioblastoma multiforme. Brain.

van Landeghem, F.K., Weiss, T., and von Deimling, A. (2007). Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of the human CNS. Regulatory peptides 142, 52-59.

Weller, M., Berger, H. Hartmann, C., SChramm, J., Westphal, M., Simon, M., Goldbrunner, R., Krex, D., Steinbach, J., Ostertag, C., Loeffler, M., Pietsch, T., von Deimling, A., (2007) Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Clinical Cancer Research 13 (23), 6933-7.

Balss, J., Meyer, J., Mueller, W., Korshunov, Al, Hartmann, C., von Deimling, A. (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116.

Kleber, S., Sancho-Martinez, I., Wiestler, B., Beisel, A., Gieffers, C., Hill, O., Thiemann, M., Mueller, W., Sykora, J., Schreglmann, N., Letellier, E., Zuliani, C., Klussmann, S. , Teodorczyk, M., Gröne, H.-J., Ganten, T., Sültmann, H., Tüttenberg, J., von Deimling, A., Regnier-Vigouroux, A., Herold-Mende, C., Martin-Villalba, A. (2008) Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell 13 (3), 235-48

Siegelin, M., Reuss, D., Habel, A., Herold-Mende, C., von Deimling, A. (2008) The flavonoid Kaempferol sensitizes human glioma cells to TRAIL- mediated apoptosis. Mol Cancer Ther 7(11): 3566-74

Michaelis, M., Rothweiler, F., Kassert, D., von Deimling, A., Doerr, H., Cinatl Jr, J. (2009) Reversal of P-glycoprotein-mediated multi-drug restistance by the MDM2 antagonist nutlin-3. Cancer Res. 69(2), 416-21

Reviews

Mueller, W., Hartmann, C., and von Deimling, A. (2002). Neuropathologie der Gliome und therapierelevante molekularbiologische Untersuchungen. Journal Onkologie 2, 10-13.

Hunter, S., Brat, D., Olson, J., von Deimling, A., Zhou, W., and van Meir, E. (2003). Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy. Int J Oncol 23, 857-869.

Hartmann, C., Mueller, W., and von Deimling, A. (2004). Pathology and molecular genetics of oligodendroglial tumors. Journal of Molecular Medicine.

Jeuken, J., von Deimling, A., and Wesseling, P. (2004). Molecular pathogenesis of oligodendroglial tumors. J Neurooncol 70, 161-181.

Bohner, G., Masuhr, F., Distl, R., Katchanov, J., Klingebiel, R., Zschenderlein, R., von Deimling, A., and van Landeghem, F. (2005). Pilocytic astrocytoma presenting as diffuse leptomeningeal gliomatosis: report of a n unique case and review of the literature. Acta Neuropathol (Berl) 110, 306-311.

Hartmann, C., Mueller, W., Lass, U., Kamel-Reid, S., and von Deimling, A. (2005). Molecular genetic analysis of oligodendroglial tumors. J Neuropath Exp Neurol 64, 10-14.

Hartmann, C., and von Deimling, A. (2005). Oligodendrogliomas: Impact of molecular genetics on treatment. Neurology India 53, 140-148.

Okuducu, A., Hahne, J., von Deimling, A., and Wernert, N. (2005). Laser-assisted microdissection, techniques and applications in pathology. International Journal of Molecular Medicine 15, 763-769.